Objective: To evaluate the growth, feeding and health of babies fed a novel infant formula milk with added long chain polyunsaturated fatty acids (LCPs) produced from single-cell sources, at concentrations similar to those found in mature breast milk. Design: Randomized double-blind control trial. Subjects: One-hundred and forty healthy, full-term infants of birth weight 2.5 ± 4.5 kg born at the Maternity Department, East Glamorgan General Hospital, Wales, whose mothers had already decided to bottle feed. Interventions: Subjects were randomized to two groups; one (control group) to receive a standard formula milk and the other to receive the trial milk with added LCPs. Milks were supplied in a double-blind fashion and given for the ®rst 12 weeks of life. Anthropometric measurements were made at recruitment, 3 months, 6 months and 1 y. Feeding diaries were completed at 6 weeks and 3 months, and a parental record was kept of any ill health suffered by the subjects during the ®rst year of life. Results: Of 140 infants recruited, 31 did not complete the protocol. Small but statistically signi®cant differences were found only in the subscapular skinfold thickness at 6 weeks and 3 months, that in the trial group being slightly higher, but unlikely to be of any clinical importance. No differences were found in the feeding patterns of the infants in the two groups. Stool patterns were similar, as were the frequencies of illness and allergy. Conclusions: This study supports the view that LCPs from single-cell sources do not have detrimental effects on the growth, feeding and general health of infants.
Introduction
Long-chain polyunsaturated fatty acids (LCPs), particularly arachidonic acid (AA, C20 : 4 n-6) and docosahexaenoic acid (DHA, C22 : 6 n-3), are important components of cell membranes in the developing brain and retina (Clandinin et al, 1980; Neuringer & Connor, 1986; Uauy et al, 1990; Farquharson et al, 1992) . They are present in human breast milk but in few infant milk formulas. Currently available evidence suggests that the presence of these LCPs in the infant diet is desirable for preterm infants, and possibly for term infants also. Breast-fed babies have higher concentrations of DHA in the phospholipids of their red cell membranes (a representative marker for other cell membranes) than their formula-fed counterparts (Makrides et al, 1994; Jorgensen et al, 1996) . Visual acuity is signi®cantly better in both preterm and term infants receiving breast milk compared to those receiving formula milk (Birch et al, 1993 (Birch et al, , 1998 Uauy-Dagach et al, 1994) .
LCP supplementation of infant milk may have a positive effect on the early visual development of preterm infants (Faldella et al, 1996; Carlson et al, 1996b) . Some studies have shown a positive effect of LCP supplementation on neurodevelopment and early visual development in term infants (Agostoni et al, 1995; Willatts et al, 1998; Birch et al, 2000; Carlson et al, 1996a) . Other studies, however, have not shown these effects (Jensen et al, 1997; Auestad et al, 1997; Lucas et al, 1999) .
Incorporation of LCPs into formula milks in a readymade form may also be bene®cial as the ability to synthesize LCPs from their parent compounds may be inadequate at birth (Kohn et al, 1994; Koletzco et al, 1996) . Furthermore there are theoretical effects of dietary fatty acids on immune function which have not been extensively studied in human infants (Meydani et al, 1993; Bell et al, 1996) .
Traditionally these LCPs were derived mainly from ®sh oils and egg yolk, but more recently they have been produced from single-cell sources under pharmaceutical conditions. In some countries LCPs derived in this way are already in use as components of infant milk formulas. However, due to limitations in the existing data, the UK Advisory Committee for Novel Foods and Processes (ACNFP) has requested a growth, acceptability and tolerance study of an infant formula milk containing LCPs from this source. This study was therefore designed to evaluate the growth, feeding and general health of babies fed with a novel milk formula containing single-cell derived LCPs added in quantities similar to those found in mature human milk (see Table 1 ).
Methods
Ethical approval was obtained for the study from Bro Taf Health Authority Local Research Ethics Committee. Term infants with a birth weight between 2.5 and 4.5 kg up to the age of 72 h and whose mothers had already decided to bottle feed were recruited by a research nurse before discharge from hospital. Written consent was obtained from the mother after verbal and written explanations of the trial from the research nurse. Infants with major congenital abnormalities and infants from multiple pregnancies were excluded from the study. Following recruitment each subject was block randomized in a double-blind fashion to one of two groups; one to receive the standard formula milk (control group), and the other to receive standard formula milk with the added LCPs (trial group). Both milks were similar in their composition, except for the added LCPs, which were in triglyceride form. The milks were supplied to the subjects' homes and used as soon as they arrived home from hospital; the subjects then remained on these milks for 12 weeks. To ensure that each subject received the correct formula milk, each mother was asked to return the bar code label from the containers they received to the supplier (Cow & Gate Nutricia). The supplier then checked this against the original randomization.
Anthropometric measurements were taken at recruitment (less than 72 h), 6 weeks ( AE 4 days), 3 months ( AE 6 days), 6 months ( AE 1 week) and 1 y ( AE 1 week) by the same research nurse, at the subjects' homes. Measurements were taken of weight to the nearest 10 g using Seca digital baby scales, supine length to the nearest millimetre with a Harpenden Neonatometer and a Raven Rollermeter mat, head circumference and mid arm circumference to the nearest millimetre with a¯exible plastic measuring tape, and triceps and subscapular skinfold thickness to the nearest millimetre with Holtain skinfold calipers. Fiveday feeding diaries were completed at 6 weeks and 3 months by parents. Parents were asked to report on the volume of milk taken at each feed, the frequency of feeds, the frequency of bowel actions and the consistency and colour of stools. They were also asked to score how well they thought their infants fed (between 1 and 5), how well the milk powder mixed with water (between 1 and 5) and how concerned they were about the infants' possetting or vomiting (between 1 and 5 ). An open-ended question about feeding was also asked to allow parents an opportunity to report any problems with their infants' feeding. A record sheet was also kept to record all consultations with health professionals and details of any illness, particularly infections or gastrointestinal upset. Parents were also asked whether their infant had suffered with any allergies during the trial period. The results were analysed statistically using Student's t-tests and chi-square tests where appropriate.
Results
One-hundred and forty infants were recruited. Thirty-one subjects dropped out of the study. Reasons for this included changing to a casein-based milk (n 15), parental decision to opt out following discharge from hospital (n 5), changing to a different formula (n 5), and others (n 6). In all, 109 subjects completed the study. The two groups had similar characteristics at recruitment (see Table 2 ), except for a small (6 mm) difference in mean occipito-frontal circumference which just reached statistical signi®cance (P 0.046). There were slightly more males in the control group compared to the trial group.
No signi®cant differences were found between the weight, occipito-frontal circumference, triceps skinfold thickness, mid-arm circumference and the length of the infants in the two groups at any stage beyond the recruitment period (see Table 3 ). Differences which reached statistical signi®cance were found in the subscapular skinfold thickness between the two groups at 6 weeks (7.8 mm in control group vs 7.3 mm in trial group; P 0.046) and at 3 months (8.3 mm in control group vs 7.6 mm in trial group; P 0.012) but these differences were not evident at 6 months or at 1 y. No signi®cant differences were found when the growth data were analysed separately for males and females. Figure 1 shows these data superimposed on standard growth centiles (Hamill et al, 1979) .
The mean volumes of milk taken by the subjects in each group over 5 days at 6 weeks and at 3 months were similar. No signi®cant differences were found between the subjects' mean feeding scores in the two groups at 6 weeks or 3 and four in the trial group (`vomiting' (2),`slow to feed' and`hungry'). In response to the same question at 3 months, only one subject in the control group was said to have a problem (`colic') and one subject in the trial group (`not satis®ed'). The scores given by the parents in both groups for their concern about possetting were similar. Stool frequency and consistency were similar in both groups with similar proportions reporting hard or¯uid (watery) stool. No subjects were said to have had abnormally coloured stools. The frequency of consultations with the primary care team, the frequency of hospital admission, gastrointestinal disturbances, upper respiratory infections and the frequency of allergic symptoms did not differ signi®cantly between the two groups.
Discussion
Despite great interest in the bene®ts of LCP supplementation of infant formula milk, data regarding the safety of LCPs derived from single-cell sources are scarce. The ®ndings of studies on the effects of LCPs on growth have yielded con¯icting results. Some have suggested that they are associated with reduced weight gain (Carlson et al, 1996a,b; Jensen et al, 1997; Montalto et al, 1996) ; others have not shown any effect (Lucas et al, 1999; Auestad et al, 1997; Makrides et al, 1999; Vanderhoof et al, 1997) . The nutritional effects of LCPs remain unclear and partly as a result of this LCPs have not been widely added to infant formula milks (Raiten et al, 1998) . It is widely accepted that growth is an important index of safety in the evaluation of novel milks in studies of infant nutrition (Carlson, 1994) ; our trial examined the growth and other characteristics of infants given LCPs from single-cell sources, and addressed the de®ciencies in previously available data. It can be concluded that the results of this trial have not demonstrated any detrimental effect of the trial milk on infant growth. The small but statistically signi®cant difference of 6 mm between the occipito-frontal circumference of the subjects in the trial and control groups at recruitment was not observed at any other age; it is a chance ®nding, and is unlikely to be of clinical importance. Small differences between the mean subscapular skinfold thicknesses of the trial and control groups (0.5 and 0.7 mm at 6 weeks and 3 months, respectively) were not re¯ected in the other growth parameters at those ages, and were not evident at 6 months and 1 y. No signi®cant differences were found between the two groups when males and females were analysed separately. This suggests that the slight preponderance of male participants in the control group could Figure 1 Weight, length and occipitofrontal circumference (OFC) in boys and girls, superimposed on standard reference growth percentiles (Hamill et al, 1979) . Triangles and wide error bars represent means and 95% con®dence intervals for control group, circles and narrow error bars represent those for trial group.
A novel infant formula milk G Morris et al account for the differences observed between the two groups. Figure 1 shows that, beyond the recruitment period, the 95% con®dence intervals for each growth measurement lie towards the mid-range or upper half of the standard centile ranges. Therefore, even if the small differences found between the growth measurements of the two groups are true effects of the trial milk, it is unlikely that effects of this magnitude are clinically important. The other indices of tolerance and general health measured in this study did not show any negative effect of single-cell derived LCP supplementation. No differences were found between the feeding patterns of the infants in the two groups; the subjects in the trial group took as much volume of milk as did their control group counterparts and parental assessment of their infants' feeding was similar in the two groups. Stool patterns were similar as were the reported incidence of minor illness and allergic symptoms.
In conclusion, our study supports the view that LCPs from single-cell sources do not have detrimental effects on the growth, feeding and general health of infants. These data represent important information in assessing the safety of supplementing infant milk formulas with LCPs from this source.
